Richard Adcock & Kahn Swick & Foti
2 shared events · Importance 3 · Last updated May 27, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Richard Adcock: Richard Adcock is the CEO of ImmunityBio and was the recipient of the FDA's warning letter regarding the misleading promotion of Nogapendekin alfa inbakicept.
Kahn Swick & Foti: Kahn Swick & Foti is a law firm that has also filed a securities class action lawsuit against ImmunityBio, representing investors who suffered losses.
Apr 02, 2026 · 132 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Richard Adcock and Kahn Swick & Foti interact across events, view sentiment trends, and discover connected entities.
Open Dashboard